Kappac Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Kappac Pharma on BSE

Search Inside the pdf :

10 Jun 2021

Result

Kappac Pharma Ltd - 506938 - Submission Of Half Yearly Disclosure On Related Party Transactions.

BSE India

In compliance with Regulation 23(9} of SEBI (Listing Obligation and Disclosure Req uirements) (Amendments) Regulations 2018, please find attached herewith disclosure on Related Party Transactions, on consolidated basis in the format specified in accordance with applicable accounting standards for the half year ended on March 31, 2021. Please acknowledge and take the same on your record. Thanking you.

pdf

Kappac Pharma Ltd.

10 Jun 2021

Result

Kappac Pharma Ltd - 506938 - Outcome Of The Board Meeting Of The Board Held On …

BSE India

This is to inform you that Outcome of the Board Meeting of t he Company held on Thursday 10th June 2021 in accordance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and ta ken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2021. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2021. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financia l resu lts as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2021 with unmodified opinion. Request you to kindly take on record the same. Thanking You.

pdf

Kappac Pharma Ltd.

10 Jun 2021

Result

Kappac Pharma Ltd - 506938 - Outcome Of The Board Meeting Of The Board Held On …

BSE India

pdf

Kappac Pharma Ltd.

03 Jun 2021, 12:33PM

Board Meeting

Kappac Pharma Ltd - 506938 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI …

BSE India

KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2021 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Thursday, June 10 2021 inter alia, to consider the Audited financial results of the company for quarter & year ended on March 31, 2021. Please take the above intimation in your records and kindly acknowledge receipts. Thanking You

pdf

Kappac Pharma Ltd.

09 Apr 2021

Company Update

Kappac Pharma Ltd - 506938 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI Listing …

BSE India

The Company has appointed SATELLITE CORPORATE SERVICES PVT LTD having Registration No.INR000003639 as Registrar and Share Transfer Agent for handling share transfers and allied matters. Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure requirements) Regulation 2015, we do hereby confirm that for the half financial year ended on March 31, 2021, all the activities in relation to both physical and electronic share transfer facilities for the Company, are maintained by Satellite Corporate Services Pvt Limited (CIN - U65990MH1994PTC077057), having its Office no. 106/107 Dattani Plaza, East West Compound, Andheri Kurla Road, Safed Pool, Sakinaka, Mumbai - 400 072.

pdf

Kappac Pharma Ltd.

06 Apr 2021

Company Update

Kappac Pharma Ltd - 506938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter and year ended on 31st March, 2021. This is for your information and records.

pdf

Kappac Pharma Ltd.

02 Apr 2021, 12:03PM

Company Update

KAPPAC PHARMA LTD. - 506938 - Statement Of Investor Complaints For The Quarter Ended March 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- ARUN BHANUBHAI VAGHASIYADesignation :- Any Other

Kappac Pharma Ltd.

30 Mar 2021

SAST

Kappac Pharma Ltd - 506938 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by NSE vide letter no. NSE/CML/2019/11 dated 2nd April 2019 and BSE vide circular no. LIST/COMP/01/2019-20 regarding trading restriction period and Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed from Thursday, 1st April 2021 till 48 hours after announcement / declaration of Unaudited Financial Results for the quarter and Financial Year ended on 31st March 2021. The date of Board Meeting will be informed in due course. Thanking you.

pdf

Kappac Pharma Ltd.

09 Feb 2021

Board Meeting

KAPPAC PHARMA LTD. - 506938 - Unaudited Financial Result For Quarter Ending 31St December 2020 Pursuant …

BSE India

In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2020. . Kindly take the same on your record and oblige. Thanking You,

pdf

Kappac Pharma Ltd.

09 Feb 2021

Result

KAPPAC PHARMA LTD. - 506938 - Unaudited Financial Result For Quarter Ending 31St December 2020 Pursuant …

BSE India

pdf

Is Kappac Pharma Ltd. worth buying?

1 Vote:

Buy 100.0%